| 1 |
35596723 | The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. | 2022 May 21 |
3 |
| 2 |
29737584 | Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression. | 2018 Aug |
3 |
| 3 |
27899980 | Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression. | 2016 Nov |
4 |
| 4 |
25778491 | HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. | 2015 |
4 |
| 5 |
25943534 | Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody. | 2015 Sep |
1 |
| 6 |
24362470 | TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells. | 2014 Mar |
5 |
| 7 |
23737485 | Potent immunomodulatory effects of the trifunctional antibody catumaxomab. | 2013 Aug 1 |
1 |
| 8 |
21953494 | Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. | 2012 Jan |
1 |
| 9 |
20622903 | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. | 2010 Sep 23 |
1 |
| 10 |
17667523 | High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. | 2007 Sep |
1 |